Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer

The detection of mutations in the epidermal growth factor receptor (EGFR) gene in tumor tissues has been established as the gold standard for predicting the efficacy of treatment with EGFR-tyrosine kinase inhibitors (EGFR-TKIs) in advanced non-small-cell lung cancer (NSCLC). The current study aimed...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Wang, Yuyan, Duan, Jianchun, Chen, Hanxiao, Bai, Hua, An, Tongtong, Zhao, Jun, Wang, Zhijie, Zhuo, Minglei, Wang, Shuhang, Wang, Jie
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403380/
https://ncbi.nlm.nih.gov/pubmed/28454414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5740
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi